date:Mar 02, 2017
unded agencies such as the FDA and CDC, and by the private sector. Professor Evalina Tacconelli, head of the Division of Infectious Diseases at the University of Tbingen said, new antibiotics targeting this priority list of pathogens will help to reduce deaths due to resistant infections around the world. Waiting any longer will cause further public health problems and dramatically impact patient care.
WHO ended its news release by stating that while more research and development is vital, it c